Cite

HARVARD Citation

    Speed, V. et al. (2020). Fixed dose rivaroxaban can be used in extremes of bodyweight: A population pharmacokinetic analysis. Journal of thrombosis and haemostasis. pp. 2296-2307. [Online]. 
  
Back to record